ICR conference moves to London

August 4, 2009
Business Services, Research and Development Conference, ICR

The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …

Bayer has solution for solvent shortage in pharma

August 4, 2009
Manufacturing and Production Bayer

German chemical company Bayer says it could have a solution to help ease the current shortage of acetonitrile, a solvent …

Covance lifted by $145m Merck deal

August 4, 2009
Research and Development CRO, Covance

Covance's late-stage development services unit helped the contract research organisation to a 7% increase in second quarter net revenues, ahead …

Avastin gets US approval in kidney cancer

August 4, 2009
Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

UCB in ‘dynamic mode’ as work begins at new biologics research centre

July 31, 2009
Research and Development UCB, biologics

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …

Crestor drives positive results for AZ

July 31, 2009
Sales and Marketing AZ, Crestor

AstraZeneca delivered a solid second quarter performance thanks to US delays to generic rivals and strong Crestor sales. The results …

Reshuffle at the top as Mylan deals with quality queries

July 31, 2009
Manufacturing and Production, Research and Development Mylan

US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009
Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

Sanofi makes bold promises with Q2 results

July 30, 2009
Sales and Marketing Sanofi-Aventis, patents

Sanofi-Aventis has promised its 2013 sales will at least match those the company made last year, despite facing huge and …

Skills council for pharma

July 30, 2009
Business Services, Manufacturing and Production training

The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …

Synexus expands

July 30, 2009
Research and Development CRO, Synexus

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …

DeHavilland launches political monitoring service for pharma

July 30, 2009
Medical Communications DeHavilland

A new online monitoring service will provide pharmaceutical decision-makers with briefings on opportunities and threats to their businesses coming from …

BMS profits surge ahead

July 30, 2009
Sales and Marketing BMS

Bristol Myers-Squibb's earnings growth massively outstripped its income in the second quarter of the year. The company saw its net …

Engaging with doctors online

July 29, 2009
Medical Communications, Sales and Marketing doctors, online communities

Digital marketing in all its forms can no longer be regarded the preserve of the 'early adopters' or young people …

Roche strengthened by swine flu

July 29, 2009
Sales and Marketing Roche

The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …

NHS faces ‘bleak’ funding prospects

July 29, 2009
NHS, healthcare

The prospects for future funding of the NHS "now look bleak", according to a new report by the King's Fund …

Genzyme cuts forecasts on production problems

July 29, 2009
Manufacturing and Production, Sales and Marketing Genzyme

The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …

WorldEvents opens office in Switzerland

July 28, 2009
Business Services WorldEvents

Event management agency WorldEvents has opened a new office in Switzerland. It has recruited Uwe Bornemann, an experienced event professional, …

Merck and Schering-Plough propose shareholder settlement

July 28, 2009
Sales and Marketing MA, Merck

Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …

GSK to co-market Amgen’s osteoporosis drug in Europe

July 28, 2009
Sales and Marketing Amgen, Deals, GSK

GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …

The Gateway to Local Adoption Series

Latest content